Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-induced Skin Inflammation. Wang Y, Huang W, Jia H, Tang Q, et al. Acta Derm Venereol 2024;104:adv40975.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Huang W, Jia H, Tang Q, et al. Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-induced Skin Inflammation. Acta Derm Venereol 2024;104:adv40975.
PMID: 39651943